Unicycive sells 3.55M shares for ~$16.3M net via ATM offering

Unicycive Therapeutics, Inc.

Sold 3,549,846 shares at average $4.56 per share since June 30, 2025.
Net proceeds after fees approximately $16.3 million.
Sales executed under November 2024 sales agreement with Guggenheim Securities.
Stock trades on Nasdaq Capital Market under ticker UNCY.

item 8.01

Unicycive Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-077497

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.